Genesis Healthcare Stock Forecast, Price & News

Genesis Healthcare's stock was trading at $1.16 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, GEN stock has decreased by 56.0% and is now trading at $0.51.
View which stocks have been most impacted by COVID-19.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genesis Healthcare in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Genesis Healthcare.

Wall Street analysts have given Genesis Healthcare a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Genesis Healthcare wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Genesis Healthcare is scheduled to release its next quarterly earnings announcement on Monday, March 15th 2021.
View our earnings forecast for Genesis Healthcare.

Genesis Healthcare, Inc. (NYSE:GEN) announced its quarterly earnings results on Monday, November, 9th. The company reported ($0.55) EPS for the quarter, missing the Zacks' consensus estimate of ($0.02) by $0.53. The firm earned $938.65 million during the quarter. Genesis Healthcare had a net margin of 1.07% and a negative return on equity of 5.06%.
View Genesis Healthcare's earnings history.

1 brokerages have issued 1-year target prices for Genesis Healthcare's shares. Their forecasts range from $0.57 to $0.57. On average, they anticipate Genesis Healthcare's share price to reach $0.57 in the next twelve months. This suggests a possible upside of 11.8% from the stock's current price.
View analysts' price targets for Genesis Healthcare.

Genesis Healthcare saw a increase in short interest in the month of October. As of October 15th, there was short interest totaling 1,150,000 shares, an increase of 21.4% from the September 30th total of 947,500 shares. Based on an average daily trading volume, of 1,230,000 shares, the days-to-cover ratio is currently 0.9 days. Currently, 2.1% of the shares of the company are short sold.
View Genesis Healthcare's Short Interest.

Some companies that are related to Genesis Healthcare include The Ensign Group (ENSG), National HealthCare (NHC), National HealthCare (NHC), Five Star Senior Living (FVE), Diversicare Healthcare Services (DVCR), Regional Health Properties (RHE) and Regional Health Properties (RHE).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Genesis Healthcare investors own include Flaherty & Crumrine Preferred Securities Income Fund (FFC), Vaxart (VXRT), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), AT&T (T), Amarin (AMRN), Government Properties Income Trust (GOV), Advanced Micro Devices (AMD), Bausch Health Companies (BHC) and Canopy Growth (CGC).

Genesis Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "GEN."

Genesis Healthcare's stock is owned by a number of institutional and retail investors. Top institutional investors include Acadian Asset Management LLC (1.25%), Squarepoint Ops LLC (0.16%), First Trust Advisors LP (0.09%) and Jane Street Group LLC (0.08%). Company insiders that own Genesis Healthcare stock include George V Hager, Jr, Joanne Susan Reifsnyder, Michael Scott Sherman, Paul David Bach, Stephen Scott Young and Thomas Divittorio.
View institutional ownership trends for Genesis Healthcare.

GEN stock was sold by a variety of institutional investors in the last quarter, including Jane Street Group LLC. Company insiders that have sold Genesis Healthcare company stock in the last year include George V Hager, Jr, Joanne Susan Reifsnyder, Paul David Bach, Stephen Scott Young, and Thomas Divittorio.
View insider buying and selling activity for Genesis Healthcare.

GEN stock was bought by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Squarepoint Ops LLC, and First Trust Advisors LP.
View insider buying and selling activity for Genesis Healthcare.

Shares of GEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of GEN stock can currently be purchased for approximately $0.51.

Genesis Healthcare has a market capitalization of $85.07 million and generates $4.57 billion in revenue each year. Genesis Healthcare employs 55,000 workers across the globe.

The official website for Genesis Healthcare is www.genesishcc.com.

Genesis Healthcare's mailing address is 101 EAST STATE STREET, KENNETT SQUARE PA, 19348. The company can be reached via phone at 610-444-6350 or via email at [email protected]